Publisher
Springer International Publishing
Reference22 articles.
1. 17th Expert Committee on the Selection and Use of Essential Medicines. Review of the available evidence on Lamotrigine for Epilepsy. Geneva, March 2009. https://www.who.int/selection_medicines/committees/expert/17/application/lamotrigine_inclusion.pdf. Accessed Mar 2019.
2. Biton V, Sackellares JC, Vuong A, Hammer AE, Barrett PS, Messenheimer JA. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology. 2005;65(11):1737–43.
3. Biton V, Di Memmo J, Shukla R, Lee YY, Poverennova I, Demchenko V, et al. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study. Epilepsy Behav. 2010;19(3):352–8.
4. Brodie MJ. Lamotrigine. Lancet. 1992;339(8806):1397–400.
5. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/carbamazepine monotherapy trial group. Lancet. 1995;345(8948):476–9.